Patents Examined by Raymond J. Henle, III
  • Therapeutic use of aerosolized S-nitrosoglutathione in cystic fibrosis
    Patent number: 6723703
    Abstract: The present invention is directed to the treatment of cystic fibrosis that involves the administration of a nitrosylating agent, such as S-nitrosoglutathione or ethyl nitrite.
    Type: Grant
    Filed: March 24, 2003
    Date of Patent: April 20, 2004
    Assignees: Duke University, University of Virginia Patent Foundation
    Inventors: Benjamin Gaston, Jonathan S. Stamler